(Q50539676)

15 March 2018

title

Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours. (English)

1 reference

15 March 2018

author name string

Wulbrand U

1

1 reference

15 March 2018

Wied M

2

1 reference

15 March 2018

Zöfel P

3

1 reference

15 March 2018

Göke B

4

1 reference

15 March 2018

Arnold R

5

1 reference

15 March 2018

Fehmann H

6

1 reference

15 March 2018

publication date

1 December 1998

1 reference

15 March 2018

European Journal of Clinical Investigation

published in

1 reference

15 March 2018

volume

28

1 reference

15 March 2018

issue

12

1 reference

15 March 2018

page(s)

1038-1049

1 reference

15 March 2018

Growth factors and carcinoid tumours

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Epidermal growth factor induces the expression of its receptor gene in human gastric carcinoma cell line TMK-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Expression of epidermal growth factor, transforming growth factor-alpha and their receptor genes in human gastric carcinomas; implication for autocrine growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

TGF beta signals through a heteromeric protein kinase receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Reduced Levels of Transforming Growth Factor‐beta Type I Receptor in Human Gastric Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Structural characterization and biological functions of fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

High incidence of somatostatin receptors in human meningiomas: biochemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Somatostatin receptor subtype expression in human tissues: a prediction for diagnosis and treatment of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Somatostatin receptor subtype mRNA expression in human colorectal cancer and normal colonic mucosae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Revised classification of neuroendocrine tumors of the lung, pancreas and gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

The IGF-I receptor in cell growth, transformation and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Somatostatin receptors in malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

21 January 2018

Somatostatin and cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

A comparison of imaging techniques for the localisation of gastro-enteropancreatic neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Messenger RNA expression of somatostatin receptor subtypes in human and rat gastric mucosae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00397.X

10.1046/J.1365-2362.1998.00397.X

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

PubMed ID

9893017

1 reference

15 March 2018